Similar articles

• Screening of drug candidates against Endothelin-1 to treat hypertension using computational based approaches: Molecular docking and dynamics simulation.

  Fatima I, Ihsan H, Masoud MS, Kalsoom S, Aslam S, Rehman A, Ashfaq UA, Qasim M. Fatima I, et al. PLoS One. 2022 Aug 18;17(8):e0269739. doi: 10.1371/journal.pone.0269739. eCollection 2022. PLoS One. 2022. Retraction in: PLoS One. 2023 Apr 26;18(4):e0284670. doi: 10.1371/journal.pone.0284670. PMID: 35981003 Free PMC article. Retracted.
• Homology modeling, molecular dynamics and virtual screening of endothelin-A receptor for the treatment of pulmonary arterial hypertension.

  Gu X, Wang Y, Wang H, Wu H, Li W, Wang J, Li N. Gu X, et al. J Biomol Struct Dyn. 2021 Jul;39(11):3912-3923. doi: 10.1080/07391102.2020.1772106. Epub 2020 Jun 8. J Biomol Struct Dyn. 2021. PMID: 32431219
• Membrane dynamics simulation and virtual screening reveals potential dual natural inhibitors of endothelin receptors for targeting glaucomatous condition.

  Nagarajan H, Vetrivel U. Nagarajan H, et al. Life Sci. 2021 Mar 15;269:119082. doi: 10.1016/j.lfs.2021.119082. Epub 2021 Jan 19. Life Sci. 2021. PMID: 33482184
• Computational Strategies to Identify New Drug Candidates against Neuroinflammation.

  Pavan M, Bassani D, Bolcato G, Bissaro M, Sturlese M, Moro S. Pavan M, et al. Curr Med Chem. 2022;29(27):4756-4775. doi: 10.2174/0929867329666220208095122. Curr Med Chem. 2022. PMID: 35135446 Review.
• Dynamic Docking: A Paradigm Shift in Computational Drug Discovery.

  Gioia D, Bertazzo M, Recanatini M, Masetti M, Cavalli A. Gioia D, et al. Molecules. 2017 Nov 22;22(11):2029. doi: 10.3390/molecules22112029. Molecules. 2017. PMID: 29165360 Free PMC article. Review.